Cochlear Launches Smart Cochlear Implant System
Cochlear's newly FDA approved Nucleus Nexa System is reportedly the world's first smart cochlear implant and features upgradeable firmware.
Tag: Cochlear Limited
All
Latest
All
Latest
Hearing Care M&As Heat Up Again
Mergers and acquisitions came back strong in 2021 after the pandemic, and M&As have started strong in 2022.
All
Latest
Survey Highlights Impact of COVID-19 on Hearing Loss
Ninety-five percent of people living with hearing loss in the United States say masks and facial coverings impact their ability to communicate during the COVID-19 pandemic, which has also heightened levels of anxiety, social isolation, and other mental health-related effects among nearly half of the nation's hearing loss community.
Cochlear Announces FDA Approval for Remote Check Solution
Remote Check is designed to be a convenient, at-home testing tool that allows Cochlear recipients with a Cochlear Nucleus 7 Sound Processor to complete a series of hearing tests from their compatible iOS device using the Nucleus Smart App.
Read More
Cochlear CEO Warns of Delay in Hearing-Related Pediatric Surgeries
According to the article, pediatric surgeries to correct hearing problems have already resumed in China, mostly in the areas outside Hubei province, where the coronavirus was most prevalent.
Read More
Cochlear Ltd Obtains FDA Approval to Lower Age of Cochlear Implantation
This approval “helps ensure children born deaf have earlier access to a cochlear implant which can provide them with the hearing capabilities to develop speech and language at a trajectory similar to their hearing peers.”
Read More
Cochlear, Ltd Warns That Demand for Implants May be Slow in China Due to Coronavirus
According to “Reuters,” Cochlear reported underlying profit of A$132.7 million ($88.78 million USD) for the six months ended December 31, slightly above the A$132.1 million it posted a year earlier.
Read More
Cochlear Cuts Full-year Profit Forecast
Cochlear, Ltd cut its full-year profit forecast due to a delay in surgeries at hospitals in China...
Read More
Cochlear Osia 2 System Receives FDA Clearance
Cochlear Limited (ASX: COH), an implantable hearing solutions company, announced the US Food and...
Read More
‘Life After Deaf’ Details Reporter’s Experience with Hearing Loss
A Pulitzer-Prize nominated reporter has penned Life After Deaf, a new book detailing his...
Read More
Cochlear Celebration to Take Place February 14-17 in Nashville
More than 1,000 Cochlear™ Nucleus® Implant and Baha® System recipients and their families from the United States and Canada will come together at the four-day convention to celebrate the joys, challenges, and personal triumphs of overcoming hearing loss, while improving their hearing performance.
Read More
Cochlear and GN Expand Smart Hearing Alliance Collaboration
The deepening of this relationship includes joint research and development, shared technology, and strengthened global Smart Hearing Alliance commercial collaboration between Cochlear and GN Hearing, the hearing aid division of the GN Group.
Read More
Cochlear Ltd to Appeal $268 Million Patent Infringement Judgement
A US District Court has awarded $268.1 million in damages against Cochlear Ltd as part of a patent infringement lawsuit filed by the Alfred E. Mann Foundation for Scientific Research and Advanced Bionics LLC.
Read More
Cochlear Limited Announces Next Phase in Development of Totally Implantable Cochlear Implant
For this next phase of research and development, a further clinical feasibility study has been initiated to evaluate the totally implantable cochlear implant technology.
Read More
University of Sydney and Cochlear Limited Study Speech Comprehension in Cochlear Implant Recipients
In the study, recently published in “Ear and Hearing,” experts have found a correlation between a computer model and the speech intelligibility in implant recipients. This might mean that by improving the performance of the model, the performance of individuals with cochlear implants may benefit in ways that have never before been explored.
Read More
Sensorion Presents SENS-401 Data at Ci2018 Conference
Data from the presented studies showed that SENS-401 protected inner ear function and enhanced sensory hair cell survival in preclinical models of acoustic trauma and, separately, cisplatin infusion.
Read More
Cochlear Announces Upcoming Release of Nucleus Smart App for Android
Cochlear implant recipients with the Nucleus® 7 Sound Processor can now control their hearing with the Nucleus Smart App from a compatible Android device, which is designed to allow them to monitor and adjust their settings, view personalized hearing information, and even locate a missing sound processor, all from the convenience of their smartphone.
Read More
Cochlear Pledges $10 Million to Johns Hopkins for Research on Impact of Hearing Loss
The Cochlear Center for Hearing and Public Health at Johns Hopkins will be a first of its kind at any academic institution, focusing on hearing loss as a global public health priority, and it will be led by one of the preeminent researchers in this area, Frank Lin, MD, PhD. The center will be dedicated to understanding and addressing the impact of hearing loss on public health.
Read More